Veterinary Pharmaceuticals Market 2023-2032: International Expansion, Growth Strategy, Global Trends And Major Players | Zoetis Inc, Merck & Co., Inc, Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, Ceva Sante Animale

As per The Business Research Company's Veterinary Pharmaceuticals Opportunities And Strategies Market Report 2023, The global veterinary pharmaceuticals market reached a value of nearly $28,708.5 million in 2022, having grown at a compound annual growth rate (CAGR) of 5.5% since 2017. The market is expected to grow from $28,708.5 million in 2022 to $38,647.4 million in 2027 at a rate of 6.1%. The market is then expected to grow at a CAGR of 6.7% from 2027 and reach $53,388.7 million in 2032.

Increasing pet ownership will drive the growth of the veterinary pharmaceuticals market during the forecast period. For instance, in April 2022, according to Forbes, 78% of pet owners acquired pets during the pandemic. Young people (ages 18 to 25) are much more likely to own a variety of pets besides cats and dogs. Furthermore, according to the 2021-2022 National Pet Owners Survey conducted by the American Pet Products Association (APPA), 70% of US households, or about 90.5 million families, owned a pet. Therefore, the increasing pet ownership is expected to drive the veterinary pharmaceuticals market going forward.

View Complete Report @
https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-market

Stem cell therapy is being adopted by veterinarians to treat orthopedic conditions such as osteoarthritis, ligament injuries and tendons in high commercial value species, such as racehorses. Stem cell therapy helps to restore motion and stimulate the regeneration of tendon, ligament and joint tissues by isolating adult stem cells from an animals' fat tissue and re-introducing these cells to reduce pain and inflammation. Some of the companies offering stem cell therapy in the USA include VetStem and MediVet. For instance, in April 2022, Boehringer Ingelheim, a German pharmaceutical company, launched RenuTend™ a stem cell therapy for horses. It improves healing of tendon and suspensory ligament injuries. It is administered intralesionally, targeting fiber alignment and reducing scar tissue formation, enhancing the quality of healing.

The top opportunities in the veterinary pharmaceuticals market segmented by type will arise in the veterinary vaccines segment, which will gain $3,793.4 million of global annual sales by 2027. The top opportunities in the veterinary pharmaceuticals market segmented by route of administration will arise in the parenteral segment, which will gain $4,530.1 million of global annual sales by 2027. The top opportunities in the veterinary pharmaceuticals market segmented by type of animal will arise in the companion animals segment, which will gain $7,103.2 million of global annual sales by 2027. The top opportunities in the veterinary pharmaceuticals market segmented by type of vaccine will arise in the attenuated vaccines segment, which will gain $3,986.2 million of global annual sales by 2027. The top opportunities in the veterinary pharmaceuticals market segmented by end user will arise in the veterinary hospitals segment, which will gain $4,400.2 million of global annual sales by 2027. The veterinary pharmaceuticals market size will gain the most in the USA at $2,201.4 million.

Veterinary Pharmaceuticals Market Segmentation:
The Veterinary Pharmaceuticals Market is segmented by type, by route of administration, type of animal, by type of vaccine and by end user.

By Type -
The veterinary pharmaceuticals market is segmented by type into:
a) Veterinary Vaccines
b) Veterinary Antibiotics
c) Veterinary Parasiticides
d) Other Veterinary Pharmaceuticals.

By Route Of Administration -
The veterinary pharmaceuticals market is segmented by route of administration into:
a) Oral
b) Parenteral
c) Topical
d) Other Routes Of Administration.
By Type Of Animal -

The veterinary pharmaceuticals market is segmented by type of animal into:
a) Livestock
b) Companion Animals
By Type Of Vaccine -

The veterinary pharmaceuticals market is segmented by type of vaccine into:
a) Inactivated Vaccines
b) Attenuated Vaccines
c) Recombinant Vaccines
d) Other Vaccines
By End User -

The veterinary pharmaceuticals market is segmented by end user into:
a) Veterinary Hospitals
b) Veterinary Clinics
c) Pharmacies
d) Drug Stores

Major players in the Veterinary Pharmaceuticals Market include Zoetis Inc, Merck & Co., Inc, Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, Ceva Sante Animale

The regions covered in the global Veterinary Pharmaceuticals Market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Download FREE SAMPLE Report - https://www.thebusinessresearchcompany.com/sample_request?id=5205&type=smp

The latest report from The Business Research Company, 'Global Veterinary Pharmaceuticals Opportunities And Strategies Market Report - Forecast To 2032,' provides a comprehensive global perspective with data and statistics from 60+ geographies, analyzing 7000+ market segments. The regional and country breakdowns section offers insights into each geography's market analysis, size, historic and forecast growth, and key strategies for industry competitiveness.

Veterinary Pharmaceuticals Market Report Table Of Content
1. Executive Summary
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
……
18. Competitive Landscape And Company Profiles
19. Key Mergers and Acquisitions
20. Opportunities And Strategies
21. Veterinary Pharmaceuticals Market, Conclusions And Recommendations
22. Appendix

PURCHASE the report @
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5205

Get to know us better:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/

This release was published on openPR.